Not medical advice. Regulatory status, checked 2026-10-20: FDA rules on the bulk substances a compounding pharmacy may use are in flux. A February 2026 HHS announcement moved about 14 peptides back toward the FDA Category 1 list, and sources disagree on the final status — check the FDA bulk-substances page (https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding) before you act. PeptideClinic is a directory, not a clinic or a pharmacy: a listing is a record, never an endorsement. It gives no dosing, no medical advice and no outcome claims, and it never lists research-chemical sellers. Confirm a provider's licence on the named state board, the FDA 503B register or the NPI registry before you book. In an emergency call 911.